Skip to main content
. 2017 Jul 27;28(10):2503–2510. doi: 10.1093/annonc/mdx340

Figure 2.

Figure 2.

Correlation between NGS-based MRD assessment in autografts and clinical outcome. (A) PFS and (B) OS of the 43 patients who did not receive post-ASCT treatment, according to MRD negativity in the autograft as determined by deep sequencing (threshold: 10−7). (C) PFS of series stratified according to different MRD levels <10−7 versus 10−7 to 10−5 versus 10−5 to 10−4 versus 10−4<. (D) OS of series stratified according to different MRD levels <10−7 versus 10−7 to 10−5 versus 10−5 to 10−4 versus 10−4<. (E) PFS and (F) OS among the 58 patients who did receive post-ASCT treatment, according to MRD negativity in the autograft as determined by deep sequencing (threshold: 10−7).